Search

everythinglearnresearchcommunity

for

Search:↓

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

Finasteride doesn't improve survival in LNCaP tumor model during off-cycle of therapy.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Dihydrotestosterone increases growth and spread of human brain cancer cells, and blocking its formation might help treat this cancer.

Antiandrogens can help treat skin conditions like acne and excessive hair in women when used carefully.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

The letter is skeptical about the effectiveness of anti-androgen therapy for COVID-19 and calls for strong evidence from clinical trials.

Antiandrogen therapy helps treat genetic hair loss.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

New steroids were effective in blocking male hormone receptors in hamster prostates.

Combination therapy for 9+ months maintains symptom improvements after stopping alpha-blockers or finasteride.

PSA might help diagnose PCOS and related skin issues, but more research is needed.

Hormonal treatments, including birth control and antiandrogens, can effectively treat acne in women.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

Testosterone replacement therapy should be used for men with low testosterone levels and symptoms of hypogonadism, after careful diagnosis and considering individual needs.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

Bald men may have a lower risk of testicular cancer.

Anti-androgens are safe and effective for treating moderate to severe adult female acne.

Using 5-alpha-reductase inhibitors may improve bladder cancer survival in men.

Finasteride significantly reduces PSA levels in men, and doctors should adjust PSA readings for those taking the drug.

Pueraria mirifica extract may help treat benign prostatic hyperplasia.

There are many treatments for common hair loss, but more trials are needed to decide which are best.

Human prostate cells produce more WISP1/CCN4 when there's not enough oxygen.

Hair loss needs more research for better treatments.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.